The largest database of trusted experimental protocols

34 protocols using ly6c hk1

1

Multiparametric Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected retro-orbitally from isoflurane-anesthetized mice. The blood was treated with ACK lysis buffer for 5 min to remove RBCs, leaving the peripheral blood leukocytes (PBLs). To determine expression of cell surface molecules, we incubated PBLs with mAb at 4°C for 20–30 min, and cells were subsequently fixed for 10 min using Cytofix Solution (BD Biosciences). The following mAb clones were used to stain processed samples: CD11a (M17/4; eBioscience), TLR4 (SA15-21; BioLegend), CD3ε (145-2C11; BioLegend), NK1.1 (PK136; eBioscience), NKp46 (29A1.4; BioLegend), F4/80 (BM8; BioLegend), TLR2 (CB225; BD Bioscience), CD19 (6D5; BioLegend), CD11c (HL3; BD Biosciences), CD4 (GK1.5; BioLegend), Ly6G (1A8; BioLegend), CD127 (A7R34; BioLegend), Ly6C (HK1.4; BioLegend), and CD8α (53-6.7; BioLegend). Flow cytometry data were acquired on a Cytek Aurora (Cytek, Bethesda, MD) and analyzed with FlowJo software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
2

Profiling Listeria-Associated Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies specific for CD16/CD32 (93), CD45 (30-F11), CD11c (N418), CD11b (M1/70), Ly6G (1A8-Ly6g), B220 (RA3-6B2), MHC-II (M5/114.15.2), CD3 (145-2C11), F4/80 (BM8), CD19 (eBio1D3) from eBioscience; Ly6C (HK1.4) and CD103 (2E7) from BioLegend were used. Data were acquired using an iCyt Synergy and analyzed with FlowJo (Tree Star). The percentage of Listeria-associated (GFP+) cells in each population was determined by using cells from mice infected with L. monocytogenes SD2001 as a negative gating control in each experiment as described previously (18 (link),19 (link)).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were acquired on LSR Fortessa or LSRII flow cytometers (BD Biosciences) and analyzed using FlowJo and softwares designed by the Division of Computer Research and Technology, NCI. Live cells were gated using forward scatter exclusion of dead cells stained with propidium iodide. The following antibodies were used for staining: TCRβ (H57-597), B220 (RA3-6B2), NK1.1 (PK136), CD11b (M1/70), CD44 (IM7), CD103 (2E7), and CD69 (H1.2F3), all from eBioscience; CD3 (2C11), CD4 (GK1.5), CD8α (53-6-7), TCRγδ (GL3), and CD11c (HL3), all from BD Biosciences; and CD45 (30-F11), CD8β (YTS156.7.7), and Ly6C (HK1.4) from BioLegend. CD1d tetramers loaded with PBS-57 and unloaded controls were obtained from the NIH tetramer facility (Emory University, Atlanta, GA, USA).
+ Open protocol
+ Expand
4

Characterizing Immune Cells in Arthritic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAIA mice were intravenously injected with control IgG, unmodified α-TNF, or CBP–α-TNF at a dose of 200 μg per mouse. On day 5, hind paws were harvested and digested in Dulbecco’s modified eagle medium supplemented with 2% FBS, collagenase D (2 mg/ml) and deoxyribonuclease I (40 μg/ml; Roche) for 30 min at 37°C. Single-cell suspensions were obtained by gently disrupting through a 70-μm cell strainer. Antibodies against the following molecules were used: anti-mouse CD45 (30-F11, BD Biosciences), F4/80 (T45-2342, BD Biosciences), Ly6G (1A8, BioLegend), Ly6C (HK1.4, BioLegend), and CD11b (M1/70, BioLegend). Fixable live/dead cell discrimination was performed using Fixable Viability Dye eFluor 455 (eBioscience) according to the manufacturer’s instructions. Following a washing step, cells were stained with specific antibodies for 20 min on ice. Flow cytometric analyses were done using a Fortessa (BD Biosciences) flow cytometer and analyzed using FlowJo software (Tree Star).
+ Open protocol
+ Expand
5

Comprehensive Immune Cell Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were blocked with 2% normal mouse serum or mouse Fc block (2.4G2, BD Biosciences). Fixable yellow (Invitrogen, L34959) was used to stain live/dead cells. Anti-mouse antibodies used were CD45.2 (104, Tonbo Biosciences), CD3 (500A2, BD Bioscience), TCRβ (H57–597, eBioscience), CD8 (53-6.7, BioLegend), CD4 (GK1.5, BioLegend), FoxP3 (FJK-16S, eBioscience), Ly6C (HK1–4, BioLegend), CD11b (M1/70, BioLegend), F4/80 (BM8, eBioscience), MHC II (M5/114.15.2, eBioscience), CD11c (N418, BioLegend), NK1.1 (PK136, BD Biosciences), IFNγ (XMG1.2, Tonbo Biosciences), H-2Db (28-14-8, eBioscience), H-2Kb (AF6–88.5.5.3, eBioscience), PD-1 (29 F.1A12, BioLegend), and PD-L1 (MIH5, eBioscience). Fluorescence was measured on BD LSR FortessaTM X-20 or BD FACSymphonyTM flow cytometer (BD Biosciences, North Ryde, New South Wales, Australia) and data analysed using FlowJo, LLC software.
+ Open protocol
+ Expand
6

Multi-Omics Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from tumor or spleen were isolated by grinding through 70-μm filters and stained with the following fluorochrome-conjugated antibodies: CD45 (30-F11, BioLegend, 103116); 7-AAD (Tonbo Biosciences, 13-6993-T200); CD3 T cells: CD3e (145-2C11, BioLegend, 100305); CD8 T cells: CD8a (53-6.7, BioLegend, 100708); CD4 T cells (GK1.5, BioLegend,100412); neutrophils and monocytes: Ly6C (HK1.4, BioLegend, 115506) and CD11b (M1/70, BioLegend, 101216); natural killer cells: NK1.1 (PK136, BioLegend, 108722), B cells: CD19 (6D5, BioLegend, 115506). For the intracellular IFNγ staining, cells were incubated for 5 h at 37°C in complete RPMI 1640 containing 2 µM Monensin, 50 ng/mL PMA, 1 µg/mL Ionomycin, followed by incubation in BD Perm buffer for 30 minutes at 4°C, washed by BD wash buffer and stained with the antibody IFNγ (XMG1.2, Biolegend, 505806). The stained cells were acquired on the Invitrogen™ Attune™ NxT acoustic flow cytometer system and the data were analyzed with using FlowJo software (BD Bioscience).
+ Open protocol
+ Expand
7

Immunolabeling of Quadriceps Muscle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quadriceps muscles were collected, fixed in 4% paraformaldehyde (PFA), and dehydrated in 30% (wt/vol) sucrose (in PBS). Cryosections that were 14 μm thick were permeabilized in acetone, blocked with 5% bovine serum albumin (BSA) for 1 h and immunolabeled with antibodies against desmin (ab32362; Abcam, Cambridge, UK), CX3CR1 (ab31331; Abcam, Cambridge, UK), CD68 (MCA1957GA; Bio-Rad, Gladesville, NSW, Australia), CD11b (M1/70; BD Biosciences, San Jose, CA, USA), or Ly6C (HK1.4; Biolegend, San Diego, CA, USA), and detected using Alexa Fluor 488-conjugated anti-rat and Alexa Fluor 568-conjugated anti-rabbit (Thermo Fisher, Australia). Sections were counterstained with Alexa Fluor 647-conjugated phalloidin (Thermo Fisher, Australia), Hoechst 33258 (Sigma-Aldrich USA, Inc.), and mounted with Prolong Gold Antifade (Thermo Fisher, Australia). Images were acquired on an Olympus FV1000 and FV3000 confocal microscope and processed using Imaris 9.2 (Bitplane). Three-dimensional (3D) thresholding analysis of desmin-positive myofibers was performed using Imaris Surfaces function. Desmin-positive and phalloidin-positive myofibers were rendered as surface objects, thresholds were applied using the automated threshold function, and voxel area data were plotted for analysis. Data were generated from ten 30-μm-thick cryosections per group (four mice per group).
+ Open protocol
+ Expand
8

Immune Cell Profiling of Prostate Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcutaneous TRAMP tumors, prostate-containing tumor, and normal prostate tissue were minced into fragments, and incubated in collagenase solution in the presence of DNase I (1 mg/ml) at 37°C for 1 h. Dissociated cells were passed through a 100 µm cell strainer. Spleens or BM extracted from mouse femurs were homogenized and passed through a 100 µm cell strainer. Cells were resuspended and stained with direct labeled Abs against: CD45 (30-F11), CD11b (M1/70), Gr-1 (RB6-8C5), Ly6G (1A8) and Ly6C (HK1.4) (BioLegend); and B220 (RA3-6B2), F4/80 (BM8) and CD11c (N418) (eBioscience). For T-cell analysis, Abs from BioLegend were used: CD3 (145-2C11), CD4 (GK1.5), CD8 (53-6.7), IFNγ (XMG1.2) and Foxp3 (MF-14). Mouse G-CSF R/CD114 Ab was from R&D Systems. For intracellular staining, Abs against phospho-STAT3 (Y705) and phosphor-STAT5 (Y694) (BioLegend) were used. Staining was performed as previously described (25 (link), 31 (link)). All samples were analyzed on an LSRIIB FACS instrument and were further analyzed with FlowJo software.
+ Open protocol
+ Expand
9

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface markers, single-cell suspensions were stained with relevant fluorochrome-conjugated monoclonal antibodies(mAbs): anti-mouse CD40 (HM40-3), CD80 (16-10A1), CD86 (GL1), and MHCII (M5/114.15.2) from eBioscience, anti-mouse CD11b (M1/70), Gr-1 (RB6-8C5), Ly6G (1A8), and Ly6C (HK1.4) from Biolegend, For intracellular staining, cells were stimulated with PMA (Sigma-Aldrich, 50 ng/ml), ionomycin (Enzo, 1 µg/ml), monensin (Enzo, 2 µg/ml). After 5 h, cells were stained with antibodies against surface markers, fixed, permeabilized, and stained with anti-IFN-γ mAb (XMG1.2, eBioscience), anti- IL-17 mAb (eBio17B7, eBioscience), or anti-TGF-β mAb (TW7-16B4, eBioscience) according to the Intracellular Staining Kit (Invitrogen) instructions. Flow cytometry was performed using the BD FACSCanto II (Becton Dickinson) and data were analyzed using FlowJo software (Treestar).
+ Open protocol
+ Expand
10

Isolation and Characterization of Colonic Lamina Propria Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LP cells were isolated as previously described by Denning et al75 (link) with modifications. Briefly, the large intestine was opened longitudinally, washed of fecal contents, and cut into pieces 0.5 cm in length. To remove epithelial cells colon tissue was subjected to 2 sequential 20-minute incubations in 30 mL RPMI with 5% fetal bovine serum and 2 mmol/L EDTA at 37°C with agitation (250 rpm). After each incubation, medium containing epithelial cells and debris was discarded. The remaining colon tissue was minced and incubated for 20 minutes in RPMI with 5% fetal bovine serum, 1 mg/mL collagenase IV (Sigma-Aldrich), and 40 U/ml DNase I (Roche) at 37°C with agitation (200 rpm). Cell suspensions were collected and passed through a 100-μm strainer and pelleted by centrifugation at 300g. Cell surface staining was performed using antibodies purchased from eBioscience (Thermo Fisher Scientific): MHCII (M5/114.15.2) and Ly6C (HK1.4) and BioLegend: CD11b (M1/70), Ly6G (1A8), and CD45 (30-F11). Fc receptors were blocked with the antibody anti-FcγRIII/II.75 (link) Samples were run on the BD FACS Canto and analyzed using FlowJo (gating strategy in Figure 4).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!